Amendment: Liminatus Pharma Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Leadership Update, Unregistered Sales of Equity Securities, Changes in Registrant's Certifying Accountant